新興生物科技 EBS
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 8.3 | 43.03 | 8.15 | 0.07 | 10,500 | 7 |
| 2025Q4 | 12.36 | 65.97 | 8.55 | -0.96 | -15,700 | -55 |
| 2025Q3 | 8.82 | 105.08 | 3.37 | 0.9 | 76,500 | 51 |
| 2025Q2 | 6.38 | -76.19 | -0.2 | 1,600 | -12 | |
| 2025Q1 | 4.86 | 46.46 | 1.19 | 49,900 | 68 | |
| 2024Q4 | 9.56 | 74.22 | -0.57 | -9,500 | -31 | |
| 2024Q3 | 8.35 | 42.8 | 2.2 | 64,500 | 115 | |
| 2024Q2 | 6.82 | 82.66 | -5.4 | -203,500 | -283 | |
| 2024Q1 | 2.53 | 109.34 | 0.17 | 39,800 | 9 | |
| 2023Q4 | 2.4 | 133.54 | -0.88 | -43,800 | -50 | |
| 2023Q3 | 3.4 | 98.33 | -5.11 | -242,100 | -263 | |
| 2023Q2 | 7.35 | 132.1 | -5.15 | -293,400 | -258 | |
| 2023Q1 | 10.36 | 103.42 | -3.71 | -148,100 | -183 | |
| 2022Q4 | 11.81 | 113.79 | 11.01 | -1.34 | -55,300 | -67 |
| 2022Q3 | 20.99 | 75.81 | 19.56 | -1.69 | -42,000 | -76 |
| 2022Q2 | 31.04 | 96 | 16.16 | -1.12 | -72,000 | -56 |
| 2022Q1 | 41.06 | 145.45 | 13.17 | -0.07 | 6,400 | -4 |
| 2021Q4 | 43.47 | 100.33 | 10.13 | 3.29 | 277,400 | 189 |
| 2021Q3 | 50.07 | 93.53 | 11.84 | -0.6 | -34,700 | -33 |
| 2021Q2 | 62.99 | 91.77 | 11.28 | 0.09 | 14,500 | 5 |